Sign In

Neil Portman

Senior Research Officer at Garvan Institute of Medical Research

Dr. Neil Portman is a Senior Research Officer at the Garvan Institute of Medical Research in Sydney, Australia. He holds a DPhil (PhD) in Molecular Parasitology from the University of Oxford, where he studied the cytoskeleton and flagellum of Trypanosoma brucei, a parasite responsible for African sleeping sickness. His research interests later expanded to the biology of eukaryotic flagella in parasitic diseases, particularly in apicomplexans, during his Vice Chancellor’s Postdoctoral Fellowship at the University of Sydney.1

Currently, Dr. Portman works in the Connie Johnson Breast Cancer Research Group at the Garvan Institute. His focus is on using molecular biology, genome editing, and proteomics to develop models of endocrine-resistant breast cancer. His goal is to identify novel therapeutic strategies to improve outcomes for patients with advanced breast cancer.13 He has contributed significantly to research on estrogen receptor-positive breast cancer and resistance mechanisms to therapies like CDK4/6 inhibitors.2

Dr. Portman has published extensively in leading journals, with recent works addressing topics such as epigenetic therapy and combination treatments for resistant breast cancers.1

Related Questions

What are Neil Portman's main research interests at the Garvan Institute?
How has Neil Portman's work impacted the treatment of breast cancer?
What specific projects is Neil Portman currently involved in?
Can you provide more details about Neil Portman's role in the Connie Johnson Breast Cancer Research Group?
What are some of Neil Portman's notable publications?
Neil Portman
Neil Portman, photo 1
Neil Portman, photo 2
Add to my network

Location

Greater Sydney Area